Tel Aviv, Israel

Avigail-Elah Baruch Leshem

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tel Aviv University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Avigail-Elah Baruch Leshem. Retrieved from https://idiyas.com/inventor/avigail-elah-baruch-leshem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Avigail-Elah Baruch Leshem: Inventor in Melanin Synthesis

Introduction

Avigail-Elah Baruch Leshem is an inventor based in Tel Aviv, Israel, and is associated with Tel Aviv University. His patent work focuses on methods and compositions for synthesizing melanin.

Latest Patents

Leshem is named on 1 patent, titled “Methods and Compositions for Melanin Synthesis.” The invention describes polymer-based droplets containing melanin or ingredients used to produce it, including tyrosine, tyrosinase, and tyrosine substrates with cleavable protecting groups. It also outlines a method in which tyrosinase oxidizes tyrosine, which then polymerizes to form melanin.

Career Highlights

Leshem’s patent reflects research into using polymer-based droplets as a setting for melanin synthesis. His work connects materials and biochemical processes to a method for producing the pigment.

Collaborations

Leshem’s listed coworkers include Ayala Lampel and Tlalit Massarano. His institutional affiliation is Tel Aviv University.

Conclusion

Avigail-Elah Baruch Leshem’s patent documents an approach to melanin synthesis using polymer-based droplets and tyrosine-related components.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…